Re: Fun with Numbers
|
2
|
Resverlogix Corp.
|
Oct 18, 2022 02:52PM
|
Re: Funding
|
1
|
Resverlogix Corp.
|
Jun 23, 2017 02:09PM
|
Re: Funds
|
4
|
Resverlogix Corp.
|
Feb 19, 2023 10:57AM
|
Re: Genentech/Roche BET inhibitor toxicity paper
|
1
|
Resverlogix Corp.
|
Apr 20, 2016 01:09PM
|
Re: Genentech/Roche BET inhibitor toxicity paper
|
2
|
Resverlogix Corp.
|
Apr 20, 2016 09:36AM
|
Re: Gilead GS-5829 Perspective
|
3
|
Zenith Epigenetics
|
Jul 21, 2017 02:54PM
|
Re: Gilead GS-5829 Perspective
|
3
|
Zenith Epigenetics
|
Jul 22, 2017 04:44PM
|
Re: Give us just one or two NR’s - money, partners & timeframe
|
3
|
Resverlogix Corp.
|
Apr 14, 2021 06:30PM
|
Re: Give us just one or two NR’s - money, partners & timeframe
|
5
|
Resverlogix Corp.
|
Apr 14, 2021 11:11AM
|
Re: Globe - Lessons from accelerated vaccine development - May 25, 2021
|
4
|
Resverlogix Corp.
|
May 27, 2021 07:08PM
|
Re: Glucose fluctuation
|
3
|
Resverlogix Corp.
|
Jun 15, 2015 02:53PM
|
Re: Glucose fluctuation
|
3
|
Resverlogix Corp.
|
Jun 15, 2015 08:24AM
|
Re: Good Grief Charlie Brown….
|
3
|
Resverlogix Corp.
|
Jul 16, 2021 01:11PM
|
Re: Good news thoughts
|
5
|
Resverlogix Corp.
|
Jan 18, 2022 12:47PM
|
Re: Goodbye March, Hello April
|
3
|
Resverlogix Corp.
|
Mar 26, 2019 03:23PM
|
Re: got filled..
|
4
|
Resverlogix Corp.
|
Sep 18, 2019 11:33AM
|
Re: got this from Sarah yesterday..
|
2
|
Resverlogix Corp.
|
Mar 04, 2022 05:58PM
|
Re: Grand Cayman
|
2
|
Resverlogix Corp.
|
Jan 01, 2023 12:08PM
|
Re: Great Discussion
|
4
|
Resverlogix Corp.
|
Oct 19, 2017 12:21PM
|
Re: Great Discussion
|
2
|
Resverlogix Corp.
|
Oct 16, 2017 05:51PM
|